Gline Matthew sold ROIV
June 30, 2026 · Form 4 insider transaction
Gline Matthew sold 76,171 shares of Roivant Sciences Ltd. at $35.39 per share, a transaction worth $2.70M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
76,171
Price
$35.39
Total value
$2.70M
InsiderGline Matthew
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeF: Shares withheld for taxes
Transaction dateJune 30, 2026
Filing dateJuly 2, 2026
Shares owned after16,659,945
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.